Cited 54 times in
Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.